Main navigation
- Programs
- Subjects
- Universities
- Destinations
- Advice
The Master of Science in Global Clinical and Pharmacovigilance Regulations program caters to professionals engaged in international and domestic clinical research and drug safety monitoring within the pharmaceutical sector. This includes roles such as overseeing clinical trial operations, maintaining trial documentation, evaluating safety information from clinical studies or post-market surveillance reports for medical products, and similar responsibilities. Contemporary practice now integrates pharmacovigilance processes with clinical research to evaluate both therapeutic advantages and potential risks of investigational and marketed products. Drug safety monitoring encompasses the comprehensive strategies employed by pharmaceutical and allied industries to track, evaluate, and document product efficacy and safety profiles. While traditionally conducted post-market approval, current approaches initiate safety assessments during early-phase human trials, typically involving healthy participants to establish baseline effects before testing on target patient populations. Clinical research represents strictly controlled investigations of pharmaceuticals, therapies, or medical equipment in human subjects, aiming to develop improved methods for disease prevention, detection, diagnosis, or treatment. Achieving these objectives requires strict adherence to regulatory-mandated protocols, research methodologies, and data management standards.